Answers are grounded in this paper and cite their sources.
Acute myeloid leukemia (AML) with mutated CEBPA (CEBPA-AML) was first recognized as a distinct subtype associated with favorable prognosis in 2002, and its diagnostic criteria and clinical management have been refined over time. However, several challenges remain, including the lack of accurate mutation-based methods for measurable residual disease (MRD) detection. Here, we developed a targeted next-generation sequencing approach for the CEBPA gene, which uses adapter-free PCR amplification of hotspot regions followed by paired-end sequencing to improve analytical performance (termed CEBPA-Trass), and evaluated its clinical performance in samples from the WT1-AM-04 study. CEBPA-Trass successfully detected a cryptic long insertion missed by conventional short-read sequencing. Analytical validation showed higher background for missense variants, whereas insertions or deletions involving three or more base pairs were rarely detected in negative controls and typically below 10⁻⁴, indicating high analytical specificity. Dilution experiments further showed linear detection of insertions or deletions involving three or more base pairs with a limit of detection of 10⁻⁴ -10⁻⁵, comparable to the sensitivity of real-time PCR-based MRD assays, and aligned with the in-frame mutation patterns currently associated with favorable-risk CEBPA-AML. Clinically, CEBPA-Trass-based MRD assessment significantly stratified relapse risk after both first and last consolidation therapy. Specifically, the assessment after last consolidation showed that more than 80% of MRD-positive patients relapsed, whereas more than 80% of MRD-negative patients remained in remission for over two years. These findings suggest that CEBPA-Trass enables accurate mutation-based MRD monitoring and may improve both the diagnosis and risk stratification of patients with CEBPA-AML.
No takes yet. Share an insight, caveat, or question.
Nakata et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: